A detailed history of Syntax Research, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 13,918 shares of ZTS stock, worth $2.12 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
13,918
Holding current value
$2.12 Million
% of portfolio
1.54%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$144.41 - $170.3 $2.01 Million - $2.37 Million
13,918 New
13,918 $2.17 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $71.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Syntax Research, Inc. Portfolio

Follow Syntax Research, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntax Research, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Syntax Research, Inc. with notifications on news.